CCX282-B: Clinical Trials

3 trials of CCX282-B, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow CCX282-B: new trials by email Literature Review of CCX282-B trials Research Report on CCX282-B

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II Study of CCX282-B in Patients With Celiac Disease
CCX282-B, Placebo - Celiac Disease
Phase 2CompletedAmgen902007-10-012025-03-06
A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease
CCX282-B - Crohn's Disease
Phase 2CompletedAmgen4362006-03-012025-03-06
Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease
CCX282-B - Crohn Disease
Phase 2CompletedAmgen702004-08-012025-03-06

Conditions studied

Crohn Disease (2)  ·  Celiac Disease (1)

Sponsors

Amgen (3)

Countries

Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Poland (1)

Results publications

PMID 23527300